Chemindex > 912-60-7
KR ▼
912-60-7 noscapine hydrochloride hydrate |
|
| 상품명칭 | noscapine hydrochloride hydrate |
| 영문 이름 | noscapine hydrochloride hydrate;Noscapine hydrochloride;Noscapine hydrochloride;1-alpha-Narcotine hydrochloride;CCRIS 8985;Capval;Coscopin hydrochloride;Coscotabs hydrochloride;Difmetus Kapseln;Germose Noscapine;Key-tusscapine hydrochloride;Longatin;Lyobex retard;Methoxyhydrastine hydrochloride;NSC 5366 hydrochloride;Narcompren hydrochloride;Narcosine hydrochloride;Narcotussin;Nectadon hydrochloride;Nipaxon;Noscapine HCl;Opian hydrochloride;Opianine hydrochloride;Stilco;Teletux;Terbenol hydrochloride;Tucotine;Tulisan;Tusscapine;Tussicure P;UNII-TTN62ITH9I;Vadebex hydrochloride;1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-((5R)-5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, hydrochloride, (3S)-;1(3H)Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, hydrochloride, (S-(R*,S*))-;Narcotine, hydrochloride (8CI);(5R)-5-[(1S)-4,5-dimethoxy-3-oxo-1,3-dihydro-2-benzofuran-1-yl]-4-methoxy-6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-6-ium chloride;hydrogen chloride 6,7-dimethoxy-3-(4-methoxy-6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-2-benzofuran-1(3H)-one (1:1:1);(5R)-5-[(1S)-4,5-dimethoxy-3-oxo-1,3-dihydro-2-benzofuran-1-yl]-4-methoxy-6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-6-ium |
| 분자식 | C22H24NO7 |
| 분자량 | 414.4279 |
| InChI | InChI=1/C22H23NO7/c1-23-8-7-11-9-14-20(29-10-28-14)21(27-4)15(11)17(23)18-12-5-6-13(25-2)19(26-3)16(12)22(24)30-18/h5-6,9,17-18H,7-8,10H2,1-4H3/p+1/t17-,18+/m1/s1 |
| cas번호 | 912-60-7 |
| EC번호 | 213-014-9 |
| 분자 구조 |  |
| 녹는 점 | 221-223℃ |
| 비등점 | 565.3°C at 760 mmHg |
| 인화점 | 295.7°C |
| 증기압 | 8.42E-13mmHg at 25°C |
| 위험성 표시 |  Xi##Irritant:; |
| 리스크 규칙 | R22:; |
| 보안 규칙 | S36:; |
| MSDS | |
- 중국에서 화학 물질을 공급할 계획이라면 ChemNet 쇼핑몰로 이동하면 중국 제조업체로부터 최신의 경쟁력있는 가격을 얻을 수 있습니다.방문하십시오
ChemNet Mall
Chemical CAS Database Service는 ChemIndex.com 에서 제공합니다. 